Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 4/20 | 0.52 |
| ▸ | CA4 known ✓ | P22748 | 3/20 | 0.52 |
| ▸ | CA5A | P35218 | 2/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.32 |
| ▸ | PEPD | P12955 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22532432 | 0.97 | — | — | |
| SCHEMBL11523560 | 0.97 | — | — | |
| Zinc Ion SCHEMBL15261876 | 0.97 | CA1 (0.50) | CA1CA4CA5ACA5BLMNA | |
| Lithium Ion SCHEMBL6795560 | 0.97 | CA1 (0.50) | CA1CA4CA5ACA5BLMNA | |
| Potassium Ion SCHEMBL10798560 | 0.97 | CA4 (0.50) | CA1CA4CA5ACA5BLMNA | |
| Water SCHEMBL28838465 | 0.97 | CA1 (0.50) | CA1CA4CA5ACA5BLMNA | |
| Potassium Ion SCHEMBL10690609 | 0.97 | CA4 (0.50) | CA1CA4CA5ACA5BLMNA | |
| Silver SCHEMBL11521326 | 0.97 | CA1 (0.50) | CA1CA4CA5ACA5BLMNA | |
| Potassium Ion SCHEMBL7214154 | 0.94 | CA4 (0.48) | CA1CA4CA5ACA5BLMNA | |
| SCHEMBL11352937 | 0.85 | CA1 (0.43) | CA1CA4CA5ACA5BLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117567555-A | Method for preparing glutathione by using enzyme method | 浙江普洛生物科技有限公司 | 2024-02-20 | — | — | CN | claimed |
| CN-116987748-A | Method for preparing pseudouridylic acid by one-step reaction | 上海合全药物研发有限公司 | 2023-11-03 | — | — | CN | claimed |
| CN-114075585-A | Preparation method of beta-nicotinamide mononucleotide | 弈柯莱生物科技(上海)股份有限公司 | 2022-02-22 | — | — | CN | claimed |
| CN-114075582-A | Preparation method and application of D-ribose-5-phosphate | 弈柯莱生物科技(上海)股份有限公司 | 2022-02-22 | — | — | CN | claimed |
| CN-106755172-B | New way for synthesizing acetyl coenzyme A and derivative products thereof by using glycolaldehyde | 中国科学院天津工业生物技术研究所 | 2020-07-28 | — | — | CN | claimed |
| CN-106755172-A | Using glycolaldehyde synthesis of acetyl coacetylase and its new way of derived product | 中国科学院天津工业生物技术研究所 | 2017-05-31 | — | — | CN | claimed |
| US-20260125713-A1 | PRODUCTION OF MOLECULES BY PERIPLASMIC ENZYMATIC CATALYSIS | BIOC3 (FR) | 2026-05-07 | — | — | US | disclosed |
| CN-119932136-A | Application of inorganic pyrophosphatase and method for synthesizing nucleoside diphosphate by using inorganic pyrophosphatase | 杭州珲益生物科技有限公司 | 2025-05-06 | — | — | CN | disclosed |
| US-20250122487-A1 | ENGINEERED ACETATE KINASE VARIANTS | CODEXIS, INC. | 2025-04-17 | — | — | US | disclosed |
| WO-2025081095-A1 | ENGINEERED ACETATE KINASE VARIANTS | CODEXIS, INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| CN-119685287-A | Acid-resistant enhanced nicotinamide riboside kinase mutant and application thereof | 南京诺云生物科技有限公司 | 2025-03-25 | — | — | CN | disclosed |
| EP-4519442-A1 | PRODUCTION OF MOLECULES BY PERIPLASMIC ENZYMATIC CATALYSIS | BIOC3 (FR) | 2025-03-12 | — | — | EP | disclosed |
| CN-119546770-A | Catalytic production of molecules by periplasmic enzymes | BIOC3公司 | 2025-02-28 | — | — | CN | disclosed |
| EP-0566140-A2 | Method for producing dinucleoside polyphosphate, nucleoside polyphosphate or derivatives thereof | UNITIKA LTD. (JP) | 1993-10-20 | — | — | EP | disclosed |
| EP-0542292-A2 | Method for producing 3'-phosphoadenosine 5'-phosphosulfate | UNITIKA LTD. (JP) | 1993-05-19 | — | — | EP | disclosed |
| US-5094947-A | PROCESS FOR PRODUCING FRUCTOSE-1,6-DIPHOSPHATE | UNITIKA, LTD. (JP) | 1992-03-10 | — | — | US | disclosed |
| EP-0385486-A1 | Process for producing fructose-1,6-diphosphate | UNITIKA LTD. (JP) | 1990-09-05 | — | — | EP | disclosed |
| US-4701285-A | Acyl phosphate salts and their use | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1987-10-20 | — | — | US | disclosed |
| US-4164444-A | Method for preparing adenosine triphosphate | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1979-08-14 | — | — | US | disclosed |
| US-4088675-A | Production of acyl phosphate salts | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1978-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125713-A1 | PRODUCTION OF MOLECULES BY PERIPLASMIC ENZYMATIC CATALYSIS | MGAM, MRPL21, NOTUM | CA1 2184/4885CA4 1106/4885CA5A 1667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.